-
Study aim
-
Comparison of Remifentanil use in spinal surgery under general anesthesia in two groups under ANI monitoring and without ANI monitoring
-
Design
-
Block and single-blind randomized clinical trial in phase 3 on 60 patients undergoing general anesthesia for spinal surgery, in two parallel control and intervention groups, with and without ANI monitoring.
-
Settings and conduct
-
In this study, a single-blind randomized clinical trial for a researcher, by not stating the size of randomization blocks, patients undergoing general anesthesia for spinal surgery at Sina Hospital in Tehran were randomly divided into two groups with and without ANI monitoring. During surgery, depending on the BIS, between 40 and 60 infusions of propofol are administered in both groups and according to ANI values, between 50 and 70 infusions of remifentanil are prescribed in the group under ANI guidance.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Patients between 18 and 70 years old, patients candidates for spinal surgery, ASA grade I-II and consent to study. Exclusion criteria: Patients with arrhythmia, patients taking beta-blockers, patients with neuromuscular diseases, diabetics and pregnant women, patients for whom pre- or postoperative ANI monitoring should be discontinued, patients who require Transfer to ICU without postoperative awakening, patients who had received medication before the intervention, lack of patient cooperation, drug addiction.
-
Intervention groups
-
Control group: Candidate patients for spinal surgery under general anesthesia without ANI monitoring;
Intervention group: Candidate patients for spinal surgery under general anesthesia under the guidance of ANI monitoring
-
Main outcome variables
-
The amount of remifentanil used during surgery; the amount of pain in recovery; The incidence of complications due to the administration of Remifentanyl.